Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 3, 2013, Pages 347-350

  Boehlen, Françoise ^a   Casini, Alessandro ^a   Pugin, François ^b   De Moerloose, Philippe ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

bariatric surgery; factor XI concentrate; factor XI deficiency; pulmonary embolism; stroke

Indexed keywords

BLOOD CLOTTING FACTOR 11;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; EPIDURAL ANESTHESIA; FEMALE; HEART FORAMEN OVALE; HUMAN; INDUCED ABORTION; INTERNAL CAROTID ARTERY OCCLUSION; LUNG EMBOLISM; OBESITY; OPERATION DURATION; PARADOXICAL EMBOLISM; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RETAINED PLACENTA; ROBOTICS; SEIZURE; VAGINAL DELIVERY;

ADULT; BARIATRIC SURGERY; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; EMBOLISM, PARADOXICAL; FACTOR XI DEFICIENCY; FATAL OUTCOME; FEMALE; FORAMEN OVALE, PATENT; GASTRIC BYPASS; HUMANS; PULMONARY EMBOLISM; STROKE;

EID: 84875818685     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835bdbec     Document Type: Article

References (31)

1. Gomez K, Bolton-Maggs P. Factor XI deficiency. Haemophilia 2008; 14:1183-1189.
2. Duga S, Salomon O. Factor XI deficiency. Semin Thromb Hemost 2009; 35:416-425.
3. Bolton-Maggs PH, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, et al. The rare coagulation disorders: review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10:593-628. (Pubitemid 39317772)
4. Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology. Haemophilia 2008; 14:671-684.
5. Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost 2009; 7 (Suppl 1):84-87.
6. Salomon O, Steinberg DM, Seligshon U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia 2006; 12:490-493. (Pubitemid 44227591)
7. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U. Patients with severe factor XI deficiency have a reduced incidence of deepvein thrombosis. Thromb Haemost 2011; 105:269-273.
8. Smith JK. Factor XI deficiency and its management. Haemophilia 1996; 2:128-136.
9. Bolton-Maggs PH. Factor XI deficiency and its management. Haemophilia 2000; 6 (Suppl 1):100-109. (Pubitemid 30468300)
10. Bolton-Maggs PH, Wensley RT, Kernoff PB, Kasper CK, Winkelman L, Lane RS, et al. Production and therapeutic use of a factor XI concentrate from plasma. Thromb Haemost 1992; 67:314-319.
11. Burnouf-Radosevich M, Burnouf T. A therapeutic, highly purified factor XI concentrate from human plasma. Transfusion 1992; 32:861-867. (Pubitemid 23001636)
12. Finks JF, English WJ, Carlin AM, Krause KR, Share DA, Banerjee M, et al. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg 2012; 255:1100-1104.
13. Steele KE, SchweitzerMA, Prokopowicz G, Shore AD, Eaton LC, Lidor AO, et al. The long-term risk of venous thromboembolism following bariatric surgery. Obes Surg 2011; 21:1371-1376.
14. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361:445-454.
15. Masoomi H, Buchberg B, Reavis KM, Mills SD, Stamos M, Nguyen NT. Factors predictive of venous thromboembolism in bariatric surgery. Am Surg 2011; 77:1403-1406.
16. Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery Practice Guideline United States. Prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 2007; 3:494-495.
17. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e227S-e277S.
18. Rugeri L, Quelin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Haemophilia 2010; 16:771-777.
19. Gueguen P, Galinat H, Blouch MT, Bridey F, Duchemin J, Le Gal G, et al. Biological determinants of bleeding in patients with heterozygous factor XI deficiency. Br J Haematol 2012; 156:245-251.
20. Gitel SN, Varon D, Schulman S, Martinowitz U. Clinical experiences of a FXI-concentrate: possible side-effects [abstract]. Thromb Haemostas 1991; 65:1157.
21. Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS. Thrombogenic potential of factor XI concentrate. Lancet 1994; 344:748- 749.
22. Evans G, Pasi KJ, Mehta A, Lee CA, Perry DJ. Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiency. Blood Coagul Fibrinolysis 1997; 8:437-440. (Pubitemid 27475690)
23. Mannucci PM, Bauer KA, Santagostino E, Faioni E, Barzegar S, Coppola R, et al. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 1994; 84:1314- 1319. (Pubitemid 24245901)
24. Richards EM, Makris MM, Cooper P, Preston FE. In vivo coagulation activation following infusion of highly purified factor XI concentrate. Br J Haematol 1997; 96:293-297. (Pubitemid 27077362)
25. Hermans C, Altisent C, Batorova A, Chambost H, De Moerloose P, Karafoulidou A, et al. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia 2009; 15:639-658.
26. Becattini C, Agnelli G, Manina G, Noya G, Rondelli F. Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis 2012; 8:108-115.
27. Santoro C, Goldberg I, Bridey F, Figgie MP, Karila-Israel D, Haviland K, et al. Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven(R), a factor XI concentrate. Haemophilia 2011; 17:777- 782.
28. Li W, Gorecki P, Semaan E, Briggs W, Tortolani AJ, D'Ayala M. Concurrent prophylactic placement of inferior vena cava filter in gastric bypass and adjustable banding operations in the Bariatric Outcomes Longitudinal Database. J Vasc Surg 2012; 55:1690-1695.
29. Overby DW, Kohn GP, Cahan MA, Dixon RG, Stavas JM,Moll S, et al. Riskgroup targeted inferior vena cava filter placement in gastric bypass patients. Obes Surg 2009; 19:451-455.
30. Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2011; 7:181-188.
31. Gargiulo NJ 3rd, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E. Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg 2006; 44:1301-1305. (Pubitemid 44828410)